title: Use of Gelatin Sponge Affects Postoperative Morbidity In Cesarean Section Patients.
abstract: BACKGROUND This study aimed to determine the effects of use of a local hemostatic gelatin sponge (GS) on postoperative morbidity in patients undergoing cesarean section (CS). MATERIAL AND METHODS The records of 318 patients who underwent CS surgery were retrospectively evaluated. Group 1 consisted of 59 patients with gelatin sponge (GS) applied, and Group 2 consisted of 259 patients with no GS applied. The groups were compared for time to the first flatus, nausea and vomiting, requirement for anti-emetic drugs, development of postoperative ileus, and the length of hospitalization. RESULTS The patients in Group 1 and Group 2 were statistically similar in mean age, gravida, parity, and body mass index (BMI) (p=0.352, p=0.275, p=0.458, and p=0.814, respectively). No significant difference was determined in the number of patients with nausea, vomiting, anti-emetic drug use, febrile morbidity, and postoperative ileus (p=0.063, p=0.436, p=328, p=0.632, and p=0.179, respectively). Time to the first flatus and length of hospitalization were significantly longer in Group 2 (p<0.001 and p<0.001, respectively). CONCLUSIONS Delay in recovery of bowel motility may be due to the local hypersensitivity reaction caused by GS and/or dislocation of this local hemostat. Women who receive gelatin sponge treatment during CS should be monitored closely for the recovery of postoperative intestinal motility.
authors.affiliation: Department of Obstetrics and Gynecology, Kahramanmaraş Sütçü İmam University Hospital, Kahramanmaraş, Turkey.
authors.forename: Alev
authors.initials: A
authors.lastname: Özer
authors.affiliation: Department of Obstetrics and Gynecology, Kahramanmaraş Sütçü İmam University Hospital, Kahramanmaraş, Turkey.
authors.forename: Bülent
authors.initials: B
authors.lastname: Köstü
mesh_terms: D000328:Adult; D000932:Antiemetics / Q000008:administration & dosage; D002585:Cesarean Section / Q000009:adverse effects* / Q000379:methods*; D005260:Female; D005769:Gastrointestinal Motility; D005781:Gelatin Sponge, Absorbable; D006801:Humans; D009017:Morbidity; D011183:Postoperative Complications / Q000209:etiology; D011184:Postoperative Period; D011247:Pregnancy; D012189:Retrospective Studies
chemical_list: D000932:Antiemetics